SLC5A2 and Crouzon syndrome-acanthosis nigricans syndrome: Ultimately, the results of our study suggest that both CAN-M and CAN-F may benefit from SGLT-2 inhibitors; however, there appear to be sex-specific benefits to CAN therapy.